Similar Search Results

Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment

Perrier, Lionel; Cautela, Nicola; Morelle, Magali; … - HAL - 2008

Background: The impact of compliance to clinical practice guidelines (CPG) on outcomes and/or costs of care has not been completely clarified.Objective: To estimate relationships between medical expenditures and compliance to CPG for initial sarcoma treatment.Research design: Selected cohorts of...

Persistent link: https://www.econbiz.de/10008792742

Examining the effects of liked and disliked television commercials on consumer brand attitudes: An application of classical conditioning principles

Smith, Peter Worthington - 1990

Advertising plays a major role in differentiating brands. Many advertisements attempt to create positive feelings through the use of humor, music, or attractive spokespersons. Marketers hope the positive emotions (i.e., positive affect) evoked by these types of ads will transfer to the...

Persistent link: https://www.econbiz.de/10009430399

The attribute structure of Internet shopping: What is important and what tradeoffs are possible between Internet, retail, and catalog formats?

Keen, Cherie Noel - 1999

The growth of Internet technology and electronic commerce has not been matched by theoretically-guided social science research. Well-developed consumer research is needed to illustrate the nature and possible scope of the Internet retail choice in the marketplace. The primary purpose of this...

Persistent link: https://www.econbiz.de/10009430606

Restraining High and Rising Cancer Drug Prices: Need for Accelerating R&D Productivity and Aligning Prices with Value

Bhardwaj, Ramesh - Volkswirtschaftliche Fakultät, … - 2015

ABSTRACT The high price of cancer drugs has become a world-wide phenomenon. In recent decades, studies have produced ample evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence that the current model of drug development needs...

Persistent link: https://www.econbiz.de/10011250913

Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation

Deconinck, Eric; Miadi-Fargier, Houda; Le Pen, Claude; … - Université Paris-Dauphine (Paris IX) - 2010

/refractory FL in France, with ICERs below those observed for other therapies in the oncology field. The cost of rituximab was partly …

Persistent link: https://www.econbiz.de/10010707184

Cancer patients’ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network

Havet, Nathalie; Morelle, Magali; Remonnay, Raphaël; … - In: The European Journal of Health Economics 13 (2012) 3, pp. 289-300

Persistent link: https://www.econbiz.de/10010993962

Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health Economics Review 4 (2014) 1, pp. 1-8

D61; H51; I18. </AbstractSection> Copyright Dabisch et al.; licensee Springer. 2014

Persistent link: https://www.econbiz.de/10010998823

Invariance Testing of the SF-36 Health Survey in Women Breast Cancer Survivors: Do Personal and Cancer-related Variables Influence the Meaning of Quality of Life Items?

Mosewich, Amber; Hadd, Valerie; Crocker, Peter; Zumbo, Bruno - In: Social Indicators Research 110 (2013) 2, pp. 559-577

Quality of life (QoL) is affected by issues specific to illness trajectory and thus, may differ, and potentially take on different meanings, at different stages in the cancer process. A widely used measure of QoL is the SF-36 Health Survey (SF-36; Ware <CitationRef CitationID="CR57">1993</CitationRef>); therefore, support for its...</citationref>

Persistent link: https://www.econbiz.de/10010999400

Stakeholder perceptions of thoracic rapid tissue donation: An exploratory study

McIntyre, Jessica; Pratt, Christie; Pentz, Rebecca D.; … - In: Social Science & Medicine 99 (2013) C, pp. 35-41

) and clinic staff (n = 9) from the Thoracic Oncology Program at Moffitt Cancer Center, in Tampa, Florida, USA. All focus …

Persistent link: https://www.econbiz.de/10011042460

Testing devices or experimental systems? Cancer clinical trials take the genomic turn

Nelson, Nicole C.; Keating, Peter; Cambrosio, Alberto; … - In: Social Science & Medicine 111 (2014) C, pp. 74-83

contemporary clinical trials in oncology are not reducible to mere drug testing. Drawing on ethnographic fieldwork and interviews … with researchers in the field of oncology from 2010 to 2013, we introduce a conceptual contrast between trials as testing … biological or clinical insights. The rise of “biomarker-driven” clinical trials in oncology, which link measurable biological …

Persistent link: https://www.econbiz.de/10011042729

1
2
3
4
5
6
7
8
9
10
Next
Last